Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lopez

Showing results (861-870 of 1,138) with videos related to

Pageof 114
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 1, 2013
HCV NS5A replication complex inhibitors. Part 3: discovery of potent analogs with distinct core topologiesOmar D Lopez, Van N Nguyen, Denis R St Laurent, et al.
Journal of Geophysical Research. Atmospheres : JGR|April 19, 2019
Airborne Observations of Reactive Inorganic Chlorine and Bromine Species in the Exhaust of Coal-Fired Power PlantsBen H Lee, Felipe D Lopez-Hilfiker, Jason C Schroder, et al.
Nature Medicine|April 14, 2026
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trialDevalingam Mahalingam, Rachna T Shroff, Benedito A Carneiro, et al.
Clinical Colorectal Cancer|March 4, 2026
Phase Ib Study to Assess the Safety of Neoadjuvant Trifluridine/Tipiracil With Concurrent Radiation in Resectable Stage II/III Rectal Cancer: The FIERCE StudyEmerson Y Chen, Nima Nabavizadeh, Nicholas D Kendsersky, et al.
Cancers|February 15, 2022
Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative ComplicationsChristopher Ryan Deig, Thomas Lee Sutton, Blake Beneville, et al.
Journal for Immunotherapy of Cancer|January 2, 2023
Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinomaMeenal Sinha, Courtney Betts, Li Zhang, et al.
Journal of Medicinal Chemistry|April 12, 2013
HCV NS5A replication complex inhibitors. Part 4. Optimization for genotype 1a replicon inhibitory activityDenis R St Laurent, Michael H Serrano-Wu, Makonen Belema, et al.
Bone Marrow Transplantation|April 12, 2025
Food insecurity prior to hematopoietic stem cell transplant is associated with malnutrition and worse outcomesMatthew A Bergens, Yen P Lowder, Yan Li, et al.
Future Oncology (London, England)|October 8, 2024
CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancerCharles D Lopez, Adel Kardosh, Emerson Y Chen, et al.
The Journal of Organic Chemistry|September 7, 2017
Development of the Large-Scale Synthesis of Tetrahydropyran Glycine, a Precursor to the HCV NS5A Inhibitor BMS-986097Arvind Mathur, Bei Wang, Daniel Smith, et al.
Pageof 114

Showing results (861-870 of 1,138) with videos related to

Sort By:
Pageof 114
Bioorganic & Medicinal Chemistry Letters|January 1, 2013
HCV NS5A replication complex inhibitors. Part 3: discovery of potent analogs with distinct core topologiesOmar D Lopez, Van N Nguyen, Denis R St Laurent, et al.
Journal of Geophysical Research. Atmospheres : JGR|April 19, 2019
Airborne Observations of Reactive Inorganic Chlorine and Bromine Species in the Exhaust of Coal-Fired Power PlantsBen H Lee, Felipe D Lopez-Hilfiker, Jason C Schroder, et al.
Nature Medicine|April 14, 2026
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trialDevalingam Mahalingam, Rachna T Shroff, Benedito A Carneiro, et al.
Clinical Colorectal Cancer|March 4, 2026
Phase Ib Study to Assess the Safety of Neoadjuvant Trifluridine/Tipiracil With Concurrent Radiation in Resectable Stage II/III Rectal Cancer: The FIERCE StudyEmerson Y Chen, Nima Nabavizadeh, Nicholas D Kendsersky, et al.
Cancers|February 15, 2022
Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative ComplicationsChristopher Ryan Deig, Thomas Lee Sutton, Blake Beneville, et al.
Journal for Immunotherapy of Cancer|January 2, 2023
Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinomaMeenal Sinha, Courtney Betts, Li Zhang, et al.
Journal of Medicinal Chemistry|April 12, 2013
HCV NS5A replication complex inhibitors. Part 4. Optimization for genotype 1a replicon inhibitory activityDenis R St Laurent, Michael H Serrano-Wu, Makonen Belema, et al.
Bone Marrow Transplantation|April 12, 2025
Food insecurity prior to hematopoietic stem cell transplant is associated with malnutrition and worse outcomesMatthew A Bergens, Yen P Lowder, Yan Li, et al.
Future Oncology (London, England)|October 8, 2024
CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancerCharles D Lopez, Adel Kardosh, Emerson Y Chen, et al.
The Journal of Organic Chemistry|September 7, 2017
Development of the Large-Scale Synthesis of Tetrahydropyran Glycine, a Precursor to the HCV NS5A Inhibitor BMS-986097Arvind Mathur, Bei Wang, Daniel Smith, et al.
Pageof 114